ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AVXL Anavex Life Sciences Corporation

3.6213
-0.1087 (-2.91%)
15 Jun 2024 - Closed
Delayed by 15 minutes

Anavex Life Sciences Financial Summary

The current AVXL market cap is 297.35M. The company's latest EPS is USD -0.5785 and P/E is -6.52.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -14.19M-13.53M-12.65M-11.29M-12.52M
Net Income -13.11M-11.28M-10.15M-8.62M-10.55M
Year End 30 September 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0054k00
Operating Income -29.11M-31.09M-41.95M-50.99M-55.76M
Net Income -26.3M-26.28M-37.91M-47.98M-47.51M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 159.19M157.81M154.39M148.07M144.52M
Total Liabilities 14.02M11.06M12.53M12.5M9.56M
Total Equity 145.17M146.76M141.85M135.58M134.96M
Year End 30 September 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 25.33M34.54M161.62M152.71M154.39M
Total Liabilities 5.04M7.31M10.8M10.21M12.53M
Total Equity 20.29M27.24M150.82M142.49M141.85M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -14.28M-21.94M-27.79M-7.32M-18.97M
Investing N/A N/A N/A N/A N/A
Financing 18.59M27.59M29.65M59k7.34M
Year End 30 September 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -18.53M-21.29M-30.38M-24.24M-27.79M
Investing N/A N/A N/A N/A N/A
Financing 17.78M28.35M153.24M21.29M29.65M
Market Cap 297.35M
Price to Earnings Ratio -6.52
Price to Sales Ratio 0
Price to Cash Ratio 2.05
Price to Book Ratio 2.18
Dividend Yield -

Share Statistics

Shares Outstanding 82.11M
Average Volume (1 week) 1.23M
Average Volume (1 Month) 1.06M
52 Week Change -59.08%
52 Week High 10.45
52 Week Low 3.25
Spread (Intraday) 18.58 (84.45%)

Company Info

Company Name Anavex Life Sciences Corporation
Address 701 s carson st
carson city, nevada 89701
Website https://www.anavex.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock